The global Virtual ICU Market Growth Accelerated by Demand for Remote Patient Monitoring

Virtual intensive care unit (ICU) provides remote patient monitoring to the critically ill patients from any geographical location. It reduces time consumption and offers enhanced services to patients in remote and rural areas. Virtual ICU platform allows specialists to monitor numerous admitted patients from a centralized location simultaneously. It incorporates multiple medical devices, electronic health records, and video conferencing that assists in capturing real-time data of patients.

The global Virtual ICU Market is estimated to be valued at US$ 6 Mn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing demand for remote patient monitoring and growing popularity of telemedicine are majorly driving the growth of the virtual ICU market. As per recent study, around 50% of ICU admissions are from remote areas with limited access to specialty care. Virtual ICU platform bridges this gap by enabling remote consultation and monitoring. Moreover, continuous technological advancement in cloud computing, big data analytics, and medical imaging further supports virtual ICU services. Initiatives by government and healthcare organizations to promote digital health are also fueling the adoption of virtual ICU systems. For instance, American Telemedicine Association is working with policymakers to expand insurance coverage for virtual ICU worldwide.

Segment Analysis

The global virtual ICU market share is segmented into hardware, software and services. The hardware segment currently dominates the market owing to high adoption of devices such as patient monitors, ventilators and multi-parameter monitors in ICU units. These devices equip care teams to remotely monitor patients and streamline workflows.

Key Takeaways

The global virtual ICU market is expected to witness high growth over the forecast period of 2024 to 2031. Virtual ICU solutions enable hospitals and healthcare organizations to cost-effectively expand critical care services to remote locations. They allow care teams to monitor high-acuity patients and streamline communication from centralized locations. The global Virtual ICU Market is estimated to be valued at US$ 6 Mn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024-2031.

Regional analysis

North America is expected to be the fastest growing regional market for virtual ICU solutionsled by increasing implementation of telemedicine and tele-ICU programs. Several hospitals in the US and Canada are adopting virtual ICU platforms to address shortage of intensive care specialists. In Asia Pacific, countries like India, Japan and China are emerging as lucrative markets due to rising medical tourism and growing burden of chronic diseases.

Key players

Key players operating in the virtual ICU market are Emergent Biosolutions Inc., SIGA Technologies Inc., Bavarian Nordic A/S, Elusys Therapeutics Inc., Ichor Medical Systems Inc., Amgen Inc., Cleveland BioLabs Inc., Dynavax Technologies Corporation, Alnylam Pharmaceuticals Inc., and XOMA Corporation. They are focusing on new product launches and partnerships to strengthen their market presence.

Get more insights on this topic: https://www.ukwebwire.com/virtual-icu-market-share-and-opportunity-analysis/